| Health / Medical Topics |
VEGFR-2 inhibitor CT-322
Pronunciation
A substance being studied in the treatment of cancer. VEGFR-2 inhibitor CT-322 may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. It is a type of vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor and a type of antiangiogenesis agent. Also called Angiocept and CT-322. (NCI Dictionary)
YOU MAY ALSO LIKE
An orally available DNA cancer vaccine containing an attenuated strain of the bacterium Salmonella typhimurium encoding murine vascular endothelial growth factor receptor…
A substance that blocks an enzyme needed to form blood vessels. Also called vascular endothelial growth factor receptor tyrosine kinase inhibitor. …
An orally bioavailable quinoline-urea derivative inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1 and 2 with potential antiangiogenesis and antineoplastic…
Human VEGFC wild-type allele is located within 4q34.1-q34.3 and is approximately 109 kb in length. This allele, which encodes vascular endothelial growth…
This gene plays a role in vasculogenesis.
Human VEGFB wild-type allele is located in the vicinity of 11q13 and is approximately 4 kb in length. This allele, which encodes…
